BioSpace News Archive

Biotech Bay

Jaguar Health Provides Updates Regarding Commercial, Educational & Product Development Programs and 2017 Results for Mytesi Since Merger (August–December 2017)

Jaguar Health today provided the following updates regarding commercial, educational and product development programs and 2017 results.

January 22, 2018
·
13 min read
Policy

Biocom Applauds Two-Year Suspension of Medical Device Tax

Biocom, the association representing the life science industry of California, issued the following statement regarding the two-year suspension of the medical device tax included in H.R. 195, legislation to end a government shutdown.

January 22, 2018
·
2 min read
Policy

Cook Medical Applauds Congressional Action to Suspend the Medical Device Excise Tax, January 1, 2018

Cook Medical Incorporated applauds the successful efforts of legislators in both the U.S. Senate and House of Representatives to suspend the medical device excise tax for two years.

January 22, 2018
·
2 min read
Business

Titan in Discussions With Braeburn Regarding U.S. Probuphine Commercialization

Braeburn’s receipt of a CRL from the FDA regarding the NDA for its injectable buprenorphine product is likely to negatively impact Braeburn’s Probuphine marketing activities as it focuses on addressing the CRL.

January 22, 2018
·
4 min read
FDA

Bay Area’s Abaxis Snags USDA Approval of New VetScan FLEX4 Rapid Test

The FLEX4 Rapid Test is the newest addition to the VetScan Rapid Test product family.

January 22, 2018
·
5 min read
MOLOGEN Presented Lefitolimod TME Data at ASCO GI 2018

The data showed that lefitolimod can significantly improve the anti-tumor effect of checkpoint inhibitors, particularly anti-PD-1 and anti-PD-L1 antibodies, and thus prolong survival in murine tumor models.

January 22, 2018
·
5 min read
Business

KEDPLASMA USA Opens Two More Plasma Collection Centers, Re-Locates a Third; Ongoing Growth Benefits Rare Disease Patients

The new and re-located centers are part of a KEDPLASMA USA five-year plan to bring the number of plasma collection centers that it owns and operates to a total of over 30 by the year 2020.

January 22, 2018
·
5 min read
Biotech Bay

BioTime Announces Clinical and Corporate Milestone Targets for 2018

BioTime will continue to focus on the core pillars of its stated strategy of Clinical Progress, Simplification and Unlocking Value for BioTime Shareholders.

January 22, 2018
·
7 min read
Teewinot Life Sciences Corporation’s Subsidiary, Teewinot Technologies, Ltd. Announced Today: Grant of a New Patent with Broad Claims to Biosynthetic Production of Cannabinoid Pharmaceuticals

Teewinot Life Sciences and its wholly owned Irish subsidiary Teewinot Technologies announced today the grant of U.S. Patent No. 9,861,609.

January 22, 2018
·
2 min read
Deals

Novartis Completes Tender Offer for Advanced Accelerator Applications S.A. and Announces Commencement of Subsequent Offering Period

The deal expands Novartis Oncology neuroendocrine tumor treatment portfolio and adds radiopharmaceutical technology platform.

January 22, 2018
·
7 min read